Skip to main content
. 2021 Aug 20;9(8):1053. doi: 10.3390/biomedicines9081053

Figure 2.

Figure 2

Assessment of the effects of treatment on the survival rate. The survival rate in sham-operated transgene-negative Hannover Sprague-Dawley (HanSD), sham-operated heterozygous Ren-2 transgenic rats (TGR), and TGR rats with aorto-caval fistula (ACF) two weeks after the creation of ACF or sham-operation, treated either with angiotensin-converting enzyme inhibitor (ACEi) alone or with 14,15-epoxyeicosatrienoic acid analog (EET-A) alone or with the combination of EET-A and ACEi.